Premium
Treatment of severe orthostatic hypotension with the somatostatin analogue octreotide
Author(s) -
Woo J.,
Or K. H.,
Teoh R.,
Nicholls M. G.
Publication year - 1990
Publication title -
australian and new zealand journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.596
H-Index - 70
eISSN - 1445-5994
pISSN - 0004-8291
DOI - 10.1111/j.1445-5994.1990.tb00432.x
Subject(s) - medicine , octreotide , orthostatic vital signs , somatostatin analogue , fludrocortisone , somatostatin , blood pressure , anesthesia , pindolol , hydrocortisone , propranolol
The long‐acting somatostatin analogue octreotide was used in a patient with severe orthostatic hypotension resistant to conventional treatment. 0.4 ug/kg octreotide given subcutaneously abolished the postural drop in systolic blood pressure for about four hours and was more effective than a combination of fludrocortisone and pindolol.